ICON Public Limited Company DSO Ratio 2011-2026 | ICLR

Annual DSO Ratio ICON Public Limited Company

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	68.5	81.1	61.3	55.8	82.6	145	148	134	131	141	135

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
148	55.8	107

Quarterly DSO Ratio ICON Public Limited Company

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	65.1	-	49.3	70	73.1	-	64	73.5	67.2	-	53.9	55.6	56.1	-	54.2	56.8	56.9	-	73	74.1	79.9	-	83.7	81	87.9	-	86.1	84.5	86.1	-	89	87.4	88.8	-	89.4	77.4	78.7	-	73.4	69.7	71.7	-	69.7	70.3	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
89.4	49.3	72.7

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Co-Diagnostics CODX	94.7	$ 1.29	-20.86 %	$ 1.72 M	USA
Agilent Technologies A	63.8	$ 111.67	-1.39 %	$ 33.9 B	USA
Castle Biosciences CSTL	50.2	$ 19.22	1.8 %	$ 557 M	USA
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Fulgent Genetics FLGT	77.4	$ 15.84	-2.16 %	$ 479 M	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Illumina ILMN	61.3	$ 141.26	-1.38 %	$ 22.5 B	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Interpace Biosciences IDXG	66.9	$ 1.8	-	$ 7.96 M	USA
CareDx, Inc CDNA	51.5	$ 19.81	-3.34 %	$ 1.06 B	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Lantheus Holdings LNTH	80.5	$ 93.52	-3.26 %	$ 6.31 B	USA
Medpace Holdings MEDP	50.4	$ 417.74	-0.34 %	$ 12.1 B	USA
Mettler-Toledo International MTD	66.4	$ 1 039.9	-0.19 %	$ 21.4 B	Schweiz
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Myriad Genetics MYGN	52.3	$ 3.61	-0.41 %	$ 334 M	USA
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
NeoGenomics NEO	77.7	$ 8.28	-0.96 %	$ 1.06 B	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
National Research Corporation NRC	29.4	$ 18.7	-1.22 %	$ 419 M	USA
Natera NTRA	81.5	$ 188.14	-4.45 %	$ 18.5 B	USA
Charles River Laboratories International CRL	65	$ 154.29	-3.04 %	$ 7.65 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Guardant Health GH	46.1	$ 94.56	-4.16 %	$ 11.9 B	USA
Personalis PSNL	63.8	$ 6.45	-3.95 %	$ 576 M	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
Senseonics Holdings SENS	1.04	$ 5.7	-2.06 %	$ 238 M	USA
Soleno Therapeutics SLNO	27	$ 52.99	-	$ 2.69 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Biomerica BMRA	57.7	$ 2.36	-2.07 %	$ 5.42 M	USA
Laboratory Corporation of America Holdings LH	52.9	$ 251.95	-0.81 %	$ 21 B	USA
Thermo Fisher Scientific TMO	70	$ 439.75	-1.87 %	$ 166 B	USA
Trinity Biotech plc TRIB	87.2	$ 0.57	-1.7 %	$ 205 M	Irlanda
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Twist Bioscience Corporation TWST	44.5	$ 48.67	-8.08 %	$ 2.91 B	USA
Neogen Corporation NEOG	66.6	$ 8.22	-2.49 %	$ 1.78 B	USA
Quest Diagnostics Incorporated DGX	44.9	$ 187.17	-0.41 %	$ 20.8 B	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA